ABEC Expands Equipment Supply Capability
The company is certified as a manufacturer of pressure vessels and components for use in China.
On Aug. 23, 2018, ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, announced that its manufacturing facility in Kells, County Meath, Ireland, has received certification from the People’s Republic of China as a qualified manufacturer of pressure vessels and components for use in China.
According to the company, the Kells site is the company’s second facility to obtain its China manufacture license (CML); its Springfield, MO facility obtained its CML in 2010. The Kells facility was granted a CML after an audit of its vessel engineering, manufacturing, and quality processes by the China Special Equipment Inspection & Research Institute.
The company reports that it has been investing in China for more than 10 years to support the expansion of China’s biotech industry, and pressure vessels are critical components of the systems used to manufacture biopharmaceuticals. The CML for Kells allows the company to provide fully-compliant systems from the United States and Europe, ensuring consistent and flexible supply in China, as well as supporting foreign companies who are establishing manufacturing facilities in China, as stated by ABEC.
Source: ABEC
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
